Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Garfield Alastair
Chief Scientific Officer at RHYTHM PHARMACEUTICALS. Filing since 2 Jul 2025.
CIK 0002027261
Company
Date
Role
Action
Shares
Amount
Of holding
RYTM
RHYTHM PHARMACEUTICALS, INC.
13 Aug 2026
Chief Scientific Officer
Sold on a plan
7,763
$912.70K
77.2%
RYTM
RHYTHM PHARMACEUTICALS, INC.
2 Jul 2025
Chief Scientific Officer
Sold on a plan
1,319
$85.48K
29.7%
2 decisions on file.
